Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 16;9(6):e022271.
doi: 10.1136/bmjopen-2018-022271.

Dual antiplatelet therapy following percutaneous coronary intervention: protocol for a systematic review

Jesse Elliott  1   2 , Shannon E Kelly  1   2 , Zemin Bai  1 , Becky Skidmore  3 , Michel Boucher  4 , Derek Y F So  5 , George A Wells  1   2
Affiliations

Dual antiplatelet therapy following percutaneous coronary intervention: protocol for a systematic review

Jesse Elliott et al. BMJ Open. .

Abstract

Introduction: Dual antiplatelet therapy (DAPT) is routinely given to patients after percutaneous coronary intervention (PCI) with stenting; however, there is ongoing debate about the optimal duration, especially in specific patient groups. In the proposed systematic review, we intend to assess the optimal duration of DAPT following PCI with stenting, with a focus on clinically relevant patient subgroups.

Methods and analysis: We will perform a comprehensive search of the published literature for randomised controlled trials (RCTs) assessing the benefits and harms of extended DAPT (>12 months) compared with short-term DAPT (6-12 months) following PCI with stenting (bare metal or drug eluting). ClinicalTrials.gov and ICTRP will also be searched to identify ongoing and completed clinical trials. Two independent reviewers will select studies for inclusion, and the risk of bias will be assessed by use of Cochrane's Risk of Bias tool. The primary outcome of interest is death (all-cause, cardiovascular, non-cardiovascular). Secondary outcomes are bleeding (major, minor, gastrointestinal), urgent target vessel revascularisation, major adverse cardiovascular events, myocardial infarction, stroke and stent thrombosis. Subgroup data will be sought for patients with prior myocardial infarction, acute coronary syndrome at presentation and diabetes, and based on smoking status and age group. Data will be analysed by random-effects meta-analysis, and separate analyses will be performed for patient subgroups. Bayesian network meta-analysis will be performed to investigate the effect of individual P2Y12 inhibitors at different DAPT durations longer than 6 months.

Ethics and dissemination: This review will provide a comprehensive overview of the available evidence of the benefits and harms associated with extending DAPT beyond 12 months following PCI with stenting and the effects on clinically important subgroups. The results of this review will inform clinical and policy decisions regarding the optimal treatment duration of DAPT following PCI with stenting.

Systematic review registration: PROSPERO no. CRD42018082587.

Keywords: dapt; dual antiplatelet therapy; percutaneous intervention.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Tanguay JF, Bell AD, Ackman ML, et al. . Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy. Can J Cardiol 2013;29:1334–45. 10.1016/j.cjca.2013.07.001 - DOI - PubMed
    1. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2014;35:2541–619. 10.1093/eurheartj/ehu278 - DOI - PubMed
    1. Valgimigli M, Bueno H, Byrne RA, et al. . 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2018;39:213–60. 10.1093/eurheartj/ehx419 - DOI - PubMed
    1. Levine GN, Bates ER, Mauri L, et al. . Guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease a report of the American College of Cardiology / American heart association task force on clinical practice guidelines. Circulation 2016;133. - PubMed
    1. Wells GA, Elliott J, Kelly S, et al. . Dual Antiplatelet Therapy following Percutaneous Coronary Intervention: a Review of the Clinical Impact of Treatment Duration. University of Ottawa: Ottawa, ON, 2017. https://cadth.ca/sites/default/files/pdf/HT0001_DAPT_Post_PCI_.pdf [Accessed 11 Feb 2019]. - PubMed

Publication types

MeSH terms

Substances